Social Media Promotional Content Under FDA Off-Label Oversight
FDA targets off-label drug promotion on social media after a decade of regulatory neglect.
David Osei-Bonsu
Reporter
David Osei-Bonsu
David Osei-Bonsu covers mlr and promotional review for The Promo Review.
1 story